Cost-Effectiveness of a Continuous Glucose Monitoring Mobile App for Patients With Type 2 Diabetes Mellitus: Analysis Simulation
Journal of Medical Internet Research2020Vol. 22(9), pp. e16053–e16053
Citations Over TimeTop 12% of 2020 papers
Shintaro Tsuji, Tomoki Ishikawa, Yasuhiro Morii, Hongjian Zhang, Teppei Suzuki, Takumi Tanikawa, Jun Nakaya, Katsuhiko Ogasawara
Abstract
Sensitivity analyses showed that, with the exception of conditions where the transition probability of insulin therapy, utility value, or increased medical costs increases, the ICER for the introduction of CGM apps was below the threshold of US $43,478/QALY used by the Central Social Insurance Medical Council. Our results provide basic data on the cost-effectiveness of introducing CGM apps, which are currently starting to come into use.
Related Papers
- → Rotator cuff repair: An analysis of utility scores and cost-effectiveness(2007)255 cited
- → Cost-Effectiveness Analysis of Augmentation Therapy for Severe α1-Antitrypsin Deficiency(2003)73 cited
- → Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)(2022)22 cited
- → Cost-Effectiveness of Computer-Tailored Smoking Cessation Advice in Primary Care: A Randomized Trial (ESCAPE)(2013)20 cited
- → Preference-based comparative effectiveness and cost–effectiveness(2012)15 cited